Dr. Mohanad Diab
Back to Articles
2026-03-055 min read

Written and medically reviewed by Dr. Mohanad Diab, Consultant Medical Oncologist, Mediclinic Abu Dhabi.

Chemotherapy with European Protocols: What Makes It Different?

European Chemotherapy Protocols


European chemotherapy protocols, developed by organizations like ESMO (European Society for Medical Oncology), are renowned for their evidence-based approach and emphasis on quality of life.


What Makes European Protocols Different?


  • Evidence-Based: Built on large-scale clinical trials across multiple European countries
  • Patient-Centered: Focus on minimizing side effects while maximizing effectiveness
  • Regularly Updated: Revised based on the latest research and clinical data
  • Quality of Life: Emphasis on maintaining patient well-being during treatment

    • Common Chemotherapy Protocols


  • FOLFOX / FOLFIRI: For colorectal cancer
  • AC-T / TC: For breast cancer
  • CHOP / R-CHOP: For lymphoma
  • Cisplatin-based: For lung and other cancers

    • Managing Side Effects


    Modern supportive care has dramatically improved the chemotherapy experience:


  • Anti-nausea medications: Prevent most nausea and vomiting
  • Growth factors: Help maintain blood cell counts
  • Targeted dosing: Personalized to minimize toxicity
  • Nutritional support: Dietitian guidance throughout treatment

    • Why Choose European-Trained Oncologists?


    Dr. Mohanad Diab trained at Karolinska University in Sweden and practiced across Scandinavia before bringing his expertise to the UAE. His patients benefit from:


  • Access to the latest European treatment protocols
  • Multidisciplinary tumor board review
  • Personalized treatment plans
  • Compassionate, patient-centered care

    • Schedule a consultation with Dr. Mohanad Diab at Mediclinic Abu Dhabi to discuss your treatment options.

    Book a Consultation

    Book a Consultation